Content about Janssen

July 25, 2012

A subsidiary of Johnson & Johnson has launched a mobile medication adherence application that it said can be used for any prescription or over-the-counter medication or supplement.

SAN DIEGO — A subsidiary of Johnson & Johnson has launched a mobile medication adherence application that it said can be used for any prescription or over-the-counter medication or supplement.

Janssen Healthcare Innovation, a unit of Janssen Research & Development announced Wednesday the launch of Care4Today Mobile Adherence, a secure messaging platform available for iPhone, Android and BlackBerry devices, among others.

January 10, 2012

Shire has acquired U.S. rights to a drug used to treat chronic constipation in women from Johnson & Johnson, the company said Tuesday.

PHILADELPHIA — Shire has acquired U.S. rights to a drug used to treat chronic constipation in women from Johnson & Johnson, the company said Tuesday.

Shire announced the acquisition of rights to Resolor (prucalopride) from J&J subsidiary Janssen Pharmaceuticals. Financial terms were not disclosed.

Shire acquired European rights to the drug in 2010 when it bought Belgian drug maker Movetis, which itself had acquired rights to the drug from Janssen.